Active Substance & Generic Molecule Directory

Imidacloprid in Malaysia: Registered Brands, Dosages & Price Comparison

Directory of all approved pharmaceutical brands containing Imidacloprid registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).

12
Registered Brands
Availability in Malaysia:
Showing 12 of 12 registered brands
MAL Reg NoBrand Formulation NameStrength / DosageClassificationRegistration HolderAction
MAL18016100HAAdvocate Spot-on Solution for Extra-Large Dogs10.00gm in 100.00mlVeterinary (MAL-V)ELANCO MALAYSIA SDN BHDCompare →
MAL18016102HAAdvocate Spot-on Solution for Large Cats10.00gm in 100.00mlVeterinary (MAL-V)ELANCO MALAYSIA SDN BHDCompare →
MAL18016018HAAdvocate Spot-on Solution for Large Dogs10.00gm in 100.00mlVeterinary (MAL-V)ELANCO MALAYSIA SDN BHDCompare →
MAL18016017HAAdvocate Spot-on Solution for Medium Dogs10.00gm in 100.00mlVeterinary (MAL-V)ELANCO MALAYSIA SDN BHDCompare →
MAL18016014HAAdvocate Spot-on Solution for Small Cats and Ferrets10.0gm in 100mlVeterinary (MAL-V)ELANCO MALAYSIA SDN BHDCompare →
MAL18016092HAAdvocate Spot-on Solution for Small Dogs10.00gm in 100mlVeterinary (MAL-V)ELANCO MALAYSIA SDN BHDCompare →
MAL26086282HAMopsion Spot-on Solutions 0.4mL/tube (for Cats)40 mg 0.4 mlVeterinary (MAL-V)MEDISPEC (M) SDN. BHD.Compare →
MAL26086286HAMopsion Spot-on Solutions 0.4mL/tube (for Dogs)40 mg 0.4 mlVeterinary (MAL-V)MEDISPEC (M) SDN. BHD.Compare →
MAL26086283HAMopsion Spot-on Solutions 0.8mL/tube (for Cats)80 mg 0.8 mlVeterinary (MAL-V)MEDISPEC (M) SDN. BHD.Compare →
MAL26086285HAMopsion Spot-on Solutions 1.0 mL/tube (for Dogs)100 mg 1 mlVeterinary (MAL-V)MEDISPEC (M) SDN. BHD.Compare →
MAL26086284HAMopsion Spot-on Solutions 2.5 mL/tube (for Dogs)250 mg 2.5 mlVeterinary (MAL-V)MEDISPEC (M) SDN. BHD.Compare →
MAL26086281HAMopsion Spot-on Solutions 4mL/tube (for Dogs)400 mg 4 mlVeterinary (MAL-V)MEDISPEC (M) SDN. BHD.Compare →

Generic Bioequivalence & Drug Substitution in Malaysia

Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.